167 related articles for article (PubMed ID: 8597126)
1. Peroxisome proliferation: current mechanisms relating to nongenotoxic carcinogenesis.
Lake BG
Toxicol Lett; 1995 Dec; 82-83():673-81. PubMed ID: 8597126
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of hepatocarcinogenicity of peroxisome-proliferating drugs and chemicals.
Lake BG
Annu Rev Pharmacol Toxicol; 1995; 35():483-507. PubMed ID: 7598504
[TBL] [Abstract][Full Text] [Related]
3. Peroxisome proliferators: their biological and toxicological effects.
Dzhekova-Stojkova S; Bogdanska J; Stojkova Z
Clin Chem Lab Med; 2001 Jun; 39(6):468-74. PubMed ID: 11506454
[TBL] [Abstract][Full Text] [Related]
4. Hepatic peroxisome proliferation in rodents and its significance for humans.
Bentley P; Calder I; Elcombe C; Grasso P; Stringer D; Wiegand HJ
Food Chem Toxicol; 1993 Nov; 31(11):857-907. PubMed ID: 8258416
[TBL] [Abstract][Full Text] [Related]
5. Differential induction and regulation of peroxisomal enzymes: predictive value of peroxisome proliferation in identifying certain nonmutagenic carcinogens.
Nemali MR; Reddy MK; Usuda N; Reddy PG; Comeau LD; Rao MS; Reddy JK
Toxicol Appl Pharmacol; 1989 Jan; 97(1):72-87. PubMed ID: 2916237
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of rodent liver carcinogenesis.
Michalopoulos GK; Eckl PM; Cruise JL; Novicki DL; Jirtle RL
Toxicol Ind Health; 1987 Jun; 3(2):119-28. PubMed ID: 3303445
[TBL] [Abstract][Full Text] [Related]
7. [Proliferation of peroxisomes and the hepatocarcinogenic process].
Palut D
Rocz Panstw Zakl Hig; 1997; 48(1):1-11. PubMed ID: 9273657
[TBL] [Abstract][Full Text] [Related]
8. Mechanistically-based human hazard assessment of peroxisome proliferator-induced hepatocarcinogenesis.
Ashby J; Brady A; Elcombe CR; Elliott BM; Ishmael J; Odum J; Tugwood JD; Kettle S; Purchase IF
Hum Exp Toxicol; 1994 Nov; 13 Suppl 2():S1-117. PubMed ID: 7857698
[TBL] [Abstract][Full Text] [Related]
9. Do peroxisome proliferating compounds pose a hepatocarcinogenic hazard to humans?
Cattley RC; DeLuca J; Elcombe C; Fenner-Crisp P; Lake BG; Marsman DS; Pastoor TA; Popp JA; Robinson DE; Schwetz B; Tugwood J; Wahli W
Regul Toxicol Pharmacol; 1998 Feb; 27(1 Pt 1):47-60. PubMed ID: 9629596
[TBL] [Abstract][Full Text] [Related]
10. Oxidative DNA damage caused by persistent peroxisome proliferation: its role in hepatocarcinogenesis.
Reddy JK; Rao MS
Mutat Res; 1989 Sep; 214(1):63-8. PubMed ID: 2671702
[TBL] [Abstract][Full Text] [Related]
11. Perturbation of rodent hepatocyte growth control by nongenotoxic hepatocarcinogens: mechanisms and lack of relevance for human health (review).
Chevalier S; Roberts RA
Oncol Rep; 1998; 5(6):1319-27. PubMed ID: 9769363
[TBL] [Abstract][Full Text] [Related]
12. Differential induction of peroxisomal and microsomal fatty-acid-oxidising enzymes by peroxisome proliferators in rat liver and kidney. Characterisation of a renal cytochrome P-450 and implications for peroxisome proliferation.
Sharma RK; Lake BG; Makowski R; Bradshaw T; Earnshaw D; Dale JW; Gibson GG
Eur J Biochem; 1989 Sep; 184(1):69-78. PubMed ID: 2776771
[TBL] [Abstract][Full Text] [Related]
13. Lack of expression of glutathione-S-transferase P, gamma-glutamyl transpeptidase, and alpha-fetoprotein messenger RNAs in liver tumors induced by peroxisome proliferators.
Rao MS; Nemali MR; Usuda N; Scarpelli DG; Makino T; Pitot HC; Reddy JK
Cancer Res; 1988 Sep; 48(17):4919-25. PubMed ID: 2457433
[TBL] [Abstract][Full Text] [Related]
14. Long-term effects of hypolipidemic peroxisome proliferator administration on hepatic hydrogen peroxide metabolism in rats.
Tamura H; Iida T; Watanabe T; Suga T
Carcinogenesis; 1990 Mar; 11(3):445-50. PubMed ID: 2311188
[TBL] [Abstract][Full Text] [Related]
15. [Peroxisome proliferation and possible cancer hazard].
Dybing E; Sanner T
Tidsskr Nor Laegeforen; 1995 Jun; 115(15):1839-41. PubMed ID: 7638833
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the hepatic effects of nafenopin and WY-14,643 on peroxisome proliferation and cell replication in the rat and Syrian hamster.
Lake BG; Evans JG; Cunninghame ME; Price RJ
Environ Health Perspect; 1993 Dec; 101 Suppl 5(Suppl 5):241-7. PubMed ID: 8013414
[TBL] [Abstract][Full Text] [Related]
17. In vitro steady-state levels of hydrogen peroxide after exposure of male F344 rats and female B6C3F1 mice to hepatic peroxisome proliferators.
Tomaszewski KE; Agarwal DK; Melnick RL
Carcinogenesis; 1986 Nov; 7(11):1871-6. PubMed ID: 3769136
[TBL] [Abstract][Full Text] [Related]
18. Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14,643) in rats.
Marsman DS; Cattley RC; Conway JG; Popp JA
Cancer Res; 1988 Dec; 48(23):6739-44. PubMed ID: 3180084
[TBL] [Abstract][Full Text] [Related]
19. Carcinogenesis by hepatic peroxisome proliferators: evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans.
Reddy JK; Lalwai ND
Crit Rev Toxicol; 1983; 12(1):1-58. PubMed ID: 6360536
[TBL] [Abstract][Full Text] [Related]
20. Contrasting hepatocytic peroxisome proliferation, lipofuscin accumulation and cell turnover for the hepatocarcinogens Wy-14,643 and clofibric acid.
Marsman DS; Goldsworthy TL; Popp JA
Carcinogenesis; 1992 Jun; 13(6):1011-7. PubMed ID: 1600604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
